<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
<PublisherName>OICC Press</PublisherName>
<JournalTitle>Journal of Nanostructure in Chemistry</JournalTitle>
<Issn>2193-8865</Issn>
<Volume>16</Volume>
<Issue>3</Issue>
<PubDate PubStatus="epublish">
<Year>2026</Year>
<Month>06</Month>
<Day>30</Day>
</PubDate>
</Journal>
<ArticleTitle>Design of a Calcium-Triggered Nanostructured Delivery System for Controlled In Vitro Release of Trypsin Inhibitor</ArticleTitle>
<VernacularTitle></VernacularTitle>
<FirstPage></FirstPage>
<LastPage></LastPage>
<ELocationID EIdType="doi">10.57647/jnsc.2026.1603.11</ELocationID>
<Language>EN</Language>
<AuthorList>
<Author>
<FirstName>Yugang</FirstName>
<LastName>Qin</LastName>
<Affiliation>Department of Hepatobiliary Surgery, Aerospace Center Hospital, Beijing, 100049, China</Affiliation>
<Identifier Source="ORCID"></Identifier>
</Author>
<Author>
<FirstName>Wenxuan</FirstName>
<LastName>Zhang</LastName>
<Affiliation>Department of Hepatobiliary Surgery, Aerospace Center Hospital, Beijing, 100049, China</Affiliation>
<Identifier Source="ORCID"></Identifier>
</Author>
<Author>
<FirstName>Bolun</FirstName>
<LastName>Zhang</LastName>
<Affiliation>Department of Hepatobiliary Surgery, Aerospace Center Hospital, Beijing, 100049, China</Affiliation>
<Identifier Source="ORCID"></Identifier>
</Author>
<Author>
<FirstName>Gaoxue</FirstName>
<LastName>Li</LastName>
<Affiliation>Department of Gastroenterology, Shouguang People’s Hospital, Shouguang, Shandong, 262702, China</Affiliation>
<Identifier Source="ORCID"></Identifier>
</Author>
<Author>
<FirstName>Yongbiao</FirstName>
<LastName>Ma</LastName>
<Affiliation>Department of Pancreatic Surgery Weifang People’s Hospital, Weifang, Shandong, 261100, China</Affiliation>
<Identifier Source="ORCID"></Identifier>
</Author>
<Author>
<FirstName>Qiang</FirstName>
<LastName>Zhang</LastName>
<Affiliation>Department of Hepatobiliary Surgery, Aerospace Center Hospital, Beijing, 100049, China</Affiliation>
<Identifier Source="ORCID"></Identifier>
</Author>
<Author>
<FirstName>Xiaojun</FirstName>
<LastName>Wei</LastName>
<Affiliation>Department of Hepatobiliary Surgery, Aerospace Center Hospital, Beijing, 100049, China</Affiliation>
<Identifier Source="ORCID"></Identifier>
</Author>
<Author>
<FirstName>Yang</FirstName>
<LastName>Xu</LastName>
<Affiliation>Department of Hepatobiliary Surgery, Aerospace Center Hospital, Beijing, 100049, China</Affiliation>
<Identifier Source="ORCID"></Identifier>
</Author>
</AuthorList>
<PublicationType>Journal Article</PublicationType>
<History>
<PubDate PubStatus="received">
<Year>2026</Year>
<Month>06</Month>
<Day>30</Day>
</PubDate>
</History>
<Abstract>We report a mesoporous silica nanoparticle platform that exploits physiological divalent ions as a benign trigger to control stage-specific protein release under gastrointestinal-mimicking in vitro conditions, using soybean trypsin inhibitor as a model cargo. Spherical pore-expanded MSNs (~300 nm, pore diameter ~3.8 nm, BET surface area ~800 m2/g) were synthesized, loaded with up to 15.6 wt% inhibitor at 75% encapsulation efficiency, and then capped with an ~8 wt% PVA–borate nanogel gate to yield PB-MSN composites containing 14.5 wt% protein. Structural, textural and dispersion analyses confirmed that the coating partially occluded pore mouths while preserving the mesoporous framework and improving colloidal stability. In a two-stage simulated gastrointestinal protocol, PB-MSNs leaked only 3.8 ± 0.5% cargo after 2 h in pH 1.2 medium, whereas uncoated MSNs released 68 ± 5% under the same conditions. Subsequent exposure to pH 7.4 buffer containing 10 mM CaCl2 triggered a rapid burst, with cumulative release reaching ~40% within 0.5 h, 78 ± 3% at 4 h and 88 ± 4% at 8 h; in Ca2+-free buffer, release remained ≤12.3 ± 1.5% over 8 h, demonstrating a sharp ion-dependent on/off effect. Trypsin activity assays showed that inhibitor liberated under triggering conditions suppressed trypsin activity to a level comparable to free inhibitor, while SGF supernatants exhibited negligible inhibition, indicating substantial retention of inhibitory function in a reductionist activity assay and minimal gastric-phase leakage. The combined data establish PVA–borate-gated MSNs as a modular, ion-responsive platform that decouples protection in acid from fast deployment in near-neutral media. While calcium-responsive carriers and borate-based dynamic networks are well established in other delivery and hydrogel contexts, the present work translates this chemistry into an MSN pore-gating architecture in which Ca²⁺ acts as a competitive borate-binding trigger to dismantle a nanoscale sacrificial gate and thereby generate a sharp ‘off/on’ release response under GI-mimicking conditions.</Abstract>
<ObjectList>
<Object Type="keyword">
<Param Name="value">Mesoporous silica nanoparticles</Param>
</Object>
<Object Type="keyword">
<Param Name="value">PVA–borate gate</Param>
</Object>
<Object Type="keyword">
<Param Name="value">Gastrointestinal targeting</Param>
</Object>
<Object Type="keyword">
<Param Name="value">Protein nanocarriers</Param>
</Object>
<Object Type="keyword">
<Param Name="value">Ion-responsive drug platform</Param>
</Object>
</ObjectList>
</Article>
</ArticleSet>